• OPEN AN ACCOUNT
Indian Indices
Sensex
72,472.33 879.09
( 1.23%)
Global Indices
Nasdaq
51,671.07 418.43
(0.82%)
Dow Jones
7,831.57 45.21
(0.58%)
Hang Seng
69,084.74 42.63
(0.06%)
Nikkei 225
10,559.70 118.10
(1.13%)
Forex
USD-INR
96.78 0.11
(0.12%)
EUR-INR
108.39 0.07
(0.07%)
GBP-INR
127.86 0.00
(0.00%)
JPY-INR
0.61 0.00
(0.21%)

EQUITY - MARKET SCREENER

IIFL Finance Ltd
Industry :  Finance & Investments
BSE Code
ISIN Demat
Book Value()
532636
INE530B01024
177.1509312
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
IIFL
17.14
25508.41
EPS(TTM)
Face Value()
Div & Yield %
34.86
2
0.67
 

Lupin receives USFDA approval for Pitolisant Tablets, 4.45 mg and 17.8 mg
Aug 17,2026
Lupin has received the final approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Pitolisant Tablets, 4.45 mg and 17.8 mg.

The U.S. FDA has approved Lupin's Pitolisant Tablets, 4.45 mg and 17.8 mg, as bioequivalent to Wakix® for the indications in the approved labeling.